Osteology Vienna: Corporate symposium focuses on Symbionic Teeth and peri-implantitis prevention

Natural teeth are protected by a soft-tissue defence barrier that helps limit plaque migration and bacterial invasion. When a tooth is lost, this protective barrier is lost too. According to Patent Medical, the Symbionic Teeth concept is designed to restore this protection by forming a mucosal defence barrier and is intended to address common biological complications associated with implant therapy. A meta-analysis has reported prevalence rates of 43% for peri-implant mucositis and 22% for peri-implantitis.

Attendees of this year’s International Osteology Symposium are invited to join the free corporate symposium on 23 April. The session, titled “Symbionic teeth—next-generation tooth replacement with a mucosal defense barrier to effectively prevent peri-implantitis”, will begin at 5 p.m. CEST in Auditorium 2 at Messe Wien. No separate registration is required.

During the session, the speakers will present scientific evidence on the mucosal defence barrier around Symbionic Teeth and discuss treatment outcomes associated with the concept, including soft-tissue health, peri-implantitis prevention and aesthetic stability over time.

More information about the corporate symposium is available at www.mypatent.com.